Latest Breaking News On - Aldose reductase inhibitor - Page 5 : comparemela.com

Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency

EMA Orphan Designation reflects high unmet need in SORD Deficiency and benefit of govorestat treatment in reducing toxic sorbitol levelsNew data published in Journal of Clinical Investigation further. | May 25, 2023

Shoshana shendelmanSheyum syedChristopher yanickMario saportaNatalie ortiz vegaXianzun taoAmandag lobatoMaeve conneightonYi zhuRiccardo perfettiAdrianap rebeloTherapeutics incEuropean medicines agencyExchange commissionClinical investigationSorbitol dehydrogenase

Applied Therapeutics Reports First Quarter 2023 Financial Results

Demonstrated Long-term Clinical Benefit of Govorestat in ACTION-Galactosemia Kids Trial Strengthened Balance Sheet with $30 Million Private Placement of Equity Phase 3 INSPIRE Trial of Govorestat in. | May 11, 2023

Maeve conneightonShoshana shendelmanAdvanz pharmaTherapeutics incCompany balance sheetExchange commissionDemonstrated long term clinical benefitGalactosemia kidsBalance sheetPrivate placementSorbitol dehydrogenaseDiabetic cardiomyopathyLong term clinical benefitGalactosemia kids phaseAdvanz europeanAldose reductase inhibitor

Applied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia Kids Trial; Company Plans to Meet with FDA Regarding Potential NDA Submission

Govorestat demonstrated consistent long-term clinical outcomes benefit across a range of functional measures in the ACTION-Galactosemia Kids trial, confirming prior biomarker dataGovorestat treatment. | June 18, 2023

United statesAdvanz pharmaShoshana shendelmanJanet thomasMaeve conneightonBrittany cudziloRiccardo perfettiGalactosemia foundationData monitoring committeeEuropean medicines agencyTherapeutics incClinical researchExchange commissionGalactosemia kidsMarketing authorization applicationAldose reductase

Applied Therapeutics Inc (APLT) Announces Clinical Benefit of Govorestat in ACTION-Galactosemia Kids Trial, Plans to Meet with FDA

Applied Therapeutics Inc (APLT) Announces Clinical Benefit of Govorestat in ACTION-Galactosemia Kids Trial, Plans to Meet with FDA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShoshana shendelmanAdvanz pharmaJanet thomasMaeve conneightonRiccardo perfettiBrittany cudziloClinical researchEuropean medicines agencyTherapeutics incExchange commissionData monitoring committeeGalactosemia foundationWall streetGalactosemia kidsAldose reductase

Applied Therapeutics, Inc Announces $30 Million Private Placement of Equity

NEW YORK, April 24, 2023 Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in. | June 18, 2023

United statesMaeve conneightonAdvanz pharmaTherapeutics incInvestment bankExchange commissionMeagher flomPrivate placementVenrock healthcare capital partnersAdvanz europeanSecurities actPre funded warrantsAldose reductase inhibitorDiabetic cardiomyopathyPrivate securities litigation reform act